Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease
NCT04161703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2020-05-04
Summary
In recent years, a number of modalities have become available for the noninvasive reduction of adipose tissue. One of those is high intensity focused ultra sound (HIFU). The study aimed to discover the effect of Focused Ultrasound on localized abdominal fat size in fatty liver patients.
Methods: In total, 40 participants with a body mass index (BMI) 30-40 kg/m2, whose age ranged between 30 and 45 years, mild to moderate fatty liver (Liver to Spleen ratio \< 1), and with waist-hip ratio (WHR) greater than 0.8 for females and greater than 0.95 for males were included. The participants were randomly assigned to two groups, one group received focused ultrasound, diet, and exercises (the study group) and the other group received exercises, and diet only (the control group), respectively. Measures were abdominal subcutaneous fat volume, abdominal visceral fat volume, and liver to spleen ratio (L/S ratio) were measured at the beginning of the study and 3 months later.
Conditions
Interventions
- PROCEDURE
-
focused ultrasound, diet and exercise
Focused Ultra Sound using a device of Mabel6 DUO Ultra Cavitation Technology produced by DAEYANG MEDICAL CO., KOREA applied on the abdominal region which extending bilaterally from the line extending from mid-axilla to iliac crest, and above from center of diaphragm to the line extending between two iliac crests below. an aerobic exercise 3 to5 times/week for 12 weeks in the form of walking on treadmill for 30 minutes with moderate intensity a weight maintenance diet, which ranged from 1700 kcal to 2200 kcal/day, which was calculated in an individual basis for each subject according to his BMR, throughout the study period (12 weeks) to ensure that the reduction in the circumference was due to the treatment intervention rather than due to their weight reduction
- PROCEDURE
-
diet and exercise
weight maintenance diet, which ranged from 1700 kcal to 2200 kcal/day, which was calculated in an individual basis for each subject according to his BMR, throughout the study period (12 weeks) to ensure that the reduction in the circumference was due to the treatment intervention rather than due to their weight reduction. All subjects in both groups (A \& B) followed an aerobic exercise 3 to5 times/week for 12 weeks in the form of walking on treadmill for 30 minutes with moderate intensity (moderate intensity = 12-14 according to Borg Scale). The beginning period will be 15 mints and increased gradually until reaching 30 mints per time.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Mona M Taha, PhD · Cairo University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-20
- Primary Completion
- 2020-02-20
- Completion
- 2020-03-20
Countries
- Egypt
Study Locations
More Related Trials
-
Fatty Liver in Pregnancy
NCT00471575 ·Status: UNKNOWN
-
The Relationship Between Fatty Liver and Breast Cancer
NCT06402084 ·Status: RECRUITING
-
Ultrasonography for Nutritional Assesment in Cirrhotic Patients
NCT04099875 ·Status: UNKNOWN
-
RFA for Treatment of Intermediate Stage HCC
NCT05281783 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound
NCT05486429 ·Status: UNKNOWN
-
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
NCT05507151 ·Status: ACTIVE_NOT_RECRUITING
-
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
NCT00949403 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Quantification of Hepatic Steatosis With Different Ultrasound Frequency
NCT05855239 ·Status: ACTIVE_NOT_RECRUITING
-
Ultrasound and Attenuation Imaging
NCT06552377 ·Status: COMPLETED
-
NAFLD Study: US vs Liver Biopsy
NCT04101162 ·Status: UNKNOWN ·Phase: NA
-
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
NCT04785937 ·Status: RECRUITING ·Phase: NA
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis
NCT03871140 ·Status: UNKNOWN
-
Fusion Imaging Contrast-enhanced Ultrasound LI-RADS
NCT04955119 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
NCT04782050 ·Status: COMPLETED ·Phase: NA
-
Quantitative US for Evaluation of Hepatic Steatosis in NAFLD
NCT04462562 ·Status: COMPLETED ·Phase: NA
-
Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver Disease
NCT04946786 ·Status: UNKNOWN
-
Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer
NCT03026452 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement
NCT02784925 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases
NCT01489787 ·Status: UNKNOWN ·Phase: NA
-
Quantitative US for Hepatic Steatosis
NCT04180631 ·Status: COMPLETED ·Phase: NA
-
Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial Intelligence
NCT06103175 ·Status: ACTIVE_NOT_RECRUITING
-
Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation
NCT05445973 ·Status: COMPLETED ·Phase: NA
-
Positive Association of US-FLI With the Severity of CAD
NCT06541132 ·Status: RECRUITING